PCDAI — Pediatric Crohn's Disease Activity Index
ورودیهای بالینی بیمار
حداقل ۱۰ — حداکثر ۶۵
حداقل ۰ — حداکثر ۱۹
حداقل ۰ — حداکثر ۲۰۰
حداقل ۰.۵ — حداکثر ۶
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Inactive0–10
- Mild10–30
- Moderate-severe30–100
The PCDAI — Pediatric Crohn's Disease Activity Index calculates calculating weight-based pediatric dosing and evaluating age-specific physiological parameters. Key inputs include abdominal pain. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
The PCDAI measures Crohn's disease activity in children from history, exam and labs. Total 0-100: <10 inactive, 10-30 mild, >30 moderate-severe.
Clinical Indication
The PCDAI — Pediatric Crohn's Disease Activity Index is indicated for bedside clinical practice to support The PCDAI measures Crohn's disease activity in children from history, exam and labs. Total 0-100: <10 inactive, 10-30 mild, >30 moderate-severe.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.
Limitations & Contraindications
Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients.
Clinical Pearls & Action Plan
Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice.
PCDAI = abdominal pain (0/5/10) + stools (0/5/10) + well-being (0/5/10) + weight (0/5/10) + height channel decrease (0/5/10) + abdominal exam (0/5/10) + perirectal disease (0/5/10) + extraintestinal manifestations (0/5/10) + hematocrit age/sex strata (0/2.5/5) + ESR (0/2.5/5) + albumin (0/5/10). Range 0-100.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| abdominal_pain | integer | Yes | Abdominal pain |
| stools | integer | Yes | Liquid stools per day |
| wellbeing | integer | Yes | General well-being / functioning |
| weight | integer | Yes | Weight change |
| height_channels | integer | Yes | Height channel decrease |
| abdominal_exam | integer | Yes | Abdominal examination |
| perirectal | integer | Yes | Perirectal disease |
| extraintestinal | integer | Yes | Extraintestinal manifestations (fever>38.5 x3d, arthritis, uveitis, erythema nodosum, pyoderma, stomatitis) |
| hematocrit | float | Yes | Hematocrit (%) |
| age_years | float | Yes | Age (years, for hematocrit strata) |
| sex | string | Yes | Sex (for hematocrit strata >=13y) |
| esr | float | Yes | ESR (mm/h) |
| albumin | float | Yes | Albumin (g/dL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–10 | Inactive | Inactive (<10) |
| 10–30 | Mild | Mild (10-30) |
| 30–100 | Moderate-severe | Moderate-severe (>30) |
Evidence-Based References (EBM)
- Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12(4):439-447.